Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/11/2019 |
| Start Date: | February 2015 |
| End Date: | December 2020 |
| Contact: | Ashley Sanders, BA |
| Email: | ashley.sanders@yale.edu |
| Phone: | 203-932-5711 |
The overall purpose of this study is to examine the effect of pregnenolone (PREG) on the
acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will
be tested by pretreating healthy individuals with PREG and then assessing their responses to
THC.
acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will
be tested by pretreating healthy individuals with PREG and then assessing their responses to
THC.
Inclusion Criteria:
- Exposed to cannabis at least once in lifetime.
Exclusion Criteria:
- Cannabis naive
- Individuals with a documented reaction/allergy to Pregnenolone
We found this trial at
1
site
West Haven, Connecticut 06516
Principal Investigator: Deepak C D'Souza, MD
Phone: 203-932-5711
Click here to add this to my saved trials
